查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800804

2025 年至 2033 年临床试验用品市场报告（按服务、阶段、治疗领域（肿瘤学、心血管疾病、呼吸系统疾病、中枢神经系统和精神障碍等）、最终用途行业和地区划分）

Clinical Trial Supplies Market Report by Services, Phase, Therapeutic Area (Oncology, Cardiovascular Diseases, Respiratory Diseases, Central Nervous System And Mental Disorders, and Others), End-Use Industry, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球临床试验用品市场规模达27亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到47亿美元，2025-2033年期间的复合年增长率（CAGR）为6.22%。慢性病盛行率的上升、严格的监管改革、临床试验的全球化、生物技术的进步、生物相似药和孤儿药的涌现，以及区块链和物联网等创新技术在供应链管理中的应用，正在加速市场的成长。

临床试验用品涵盖了进行严格且可控的医学实验以评估新药、疗法或医疗器材的安全性和有效性所必需的各种材料和资源。它们对于确保临床试验的顺利进行至关重要，为研究人员提供必要的工具和物质来实施治疗、收集资料并保持符合监管标准。临床试验用品包括研究药物、安慰剂、医疗器材和生物样本。它们的用途扩展到在人体上测试新型疗法和干预措施，以评估其治疗效果。管理良好的临床试验用品的优点包括能够维持试验盲法、确保准确的资料收集，并最终促进医学知识的进步。

全球临床试验用品市场受到慢性病日益增长的盛行率和对创新疗法日益增长的需求的影响。此外，旨在简化药物开发流程的监管改革和指导方针促使製药公司加强对临床试验的投入，进一步推动了市场成长。同时，在追求多样化患者群体和成本效益运作的推动下，临床试验的全球化带来了对试验用品的更大需求，这反过来又加速了市场的成长。此外，生物技术和个人化医疗的进步增加了临床试验的复杂性，进一步促进了市场的成长。此外，生物相似药和孤儿药的出现扩大了临床试验的范围，从而推动了市场的成长。

临床试验用品市场趋势/驱动因素：

慢性病盛行率不断上升

癌症、糖尿病和心血管疾病等慢性疾病的增加是全球临床试验用品市场的重要驱动力。随着人口老化和生活方式的转变，这些疾病的盛行率在全球范围内稳步上升。因此，製药公司被迫开发新药和新疗法，临床试验的数量也随之激增。这一趋势不仅刺激了对临床试验用品的需求，也凸显了有效且高效的药物开发流程对于应对这些健康挑战的迫切性。此外，慢性疾病特定治疗领域（如肿瘤学或神经病学）对专用用品的需求加剧了供应链的复杂性，使其成为市场参与者关注的重点领域。

监理改革与指导方针

全球各地卫生部门和机构发布的监管改革和指南在推动临床试验用品市场发展方面发挥关键作用。这些法规旨在规范和加快药物研发流程，同时确保病人安全。製药和生物技术领域的公司必须遵守这些指南，以便进行严格合规的临床试验。因此，对高品质用品的需求日益增长，以满足监管要求。这个驱动因素不仅强调了遵守严格标准的重要性，也凸显了高效率的供应链管理和文件记录的重要性，以便成功应对复杂的监管环境。

临床试验的全球化

临床试验的全球化是临床试验用品市场的另一个关键驱动力。製药公司越来越多地在多个国家进行试验，以接触不同的患者群体、加快招募速度并降低成本。这一趋势在拥有大量患者群体的新兴市场尤为明显。因此，对临床试验用品的需求已不限于特定地区，而是在全球范围内不断扩张。这项驱动力也凸显了对强大的物流和供应链网路的需求，这些网路能够有效地支援在不同地理位置进行的试验，而这些试验通常具有不同的监管要求。此外，全球化要求在语言、文化和当地基础设施方面具有适应性，这增加了供应链管理流程的复杂性。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球临床试验用品市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依服务

  • 产品製造
  • 包装、标籤和储存
  • 物流与配送

第七章：市场区隔：依阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 其他的

第八章：市场区隔：依治疗领域

  • 肿瘤学
  • 心血管疾病
  • 呼吸系统疾病
  • 中枢神经系统和精神障碍
  • 其他的

第九章：市场区隔：依最终用途产业

  • 医疗器材业
  • 生物製药业
  • 製药业
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Almac Group Ltd.
    • Catalent Pharma Solutions Inc.
    • DHL
    • Parexel
    • Thermo Fisher Scientific Inc.
    • PCI Services
    • Sharp Clinical
    • Biocair
    • Movianto
Product Code: SR112025A2104

The global clinical trial supplies market size reached USD 2.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033. Increasing prevalence of chronic diseases, stringent regulatory reforms, the globalization of clinical trials, advancements in biotechnology, the emergence of biosimilars and orphan drugs, and the adoption of innovative technologies like blockchain and IoT for supply chain management are accelerating the market growth.

Clinical trial supplies encompass a wide range of materials and resources essential for conducting rigorous and controlled medical experiments to evaluate the safety and efficacy of new drugs, therapies, or medical devices. They are crucial in ensuring the smooth execution of clinical trials, providing researchers with the necessary tools and substances to administer treatments, collect data, and maintain compliance with regulatory standards. Clinical trial supplies consist of investigational drugs, placebos, medical devices, and biological samples. Their uses extend to the testing of novel treatments and interventions on human subjects to assess their therapeutic effects. Advantages of well-managed clinical trial supplies include the ability to maintain trial blinding, ensuring accurate data collection, and ultimately advancing medical knowledge.

The global clinical trial supplies market is influenced by the increasing prevalence of chronic diseases and the growing demand for innovative therapies. Moreover, regulatory reforms and guidelines aimed at streamlining the drug development process have prompted pharmaceutical companies to invest more in clinical trials, further propelling the market growth. In line with this, the globalization of clinical trials, driven by the pursuit of diverse patient populations and cost-effective operations, has created a greater need for trial supplies, which, in turn, is accelerating the market growth. Additionally, advancements in biotechnology and personalized medicine are increasing the complexity of clinical trials, further boosting the market growth. Apart from this, the emergence of biosimilars and orphan drugs has expanded the scope of clinical trials, which is fueling the market growth.

Clinical Trial Supplies Market Trends/Drivers:

Increasing prevalence of chronic diseases

The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, is a significant driver of the global clinical trial supplies market. With an aging population and shifting lifestyle patterns, the prevalence of these conditions is steadily increasing worldwide. As a result, pharmaceutical companies are compelled to develop new drugs and therapies, necessitating an upsurge in clinical trials. This trend not only fuels the demand for clinical trial supplies but also underscores the urgency for effective and efficient drug development processes to address these health challenges. Furthermore, the need for specialized supplies for specific therapeutic areas within chronic diseases, like oncology or neurology, contributes to the complexity of the supply chain, making it a critical focus area for market players.

Regulatory reforms and guidelines

Regulatory reforms and guidelines issued by health authorities and agencies worldwide play a pivotal role in driving the clinical trial supplies market. These regulations aim to standardize and expedite the drug development process while ensuring patient safety. Companies operating in the pharmaceutical and biotechnology sectors must adhere to these guidelines, necessitating rigorous and compliant clinical trials. As a result, there is a growing demand for high-quality supplies to meet regulatory requirements. This driver not only underscores the importance of adherence to strict standards but also emphasizes the need for efficient supply chain management and documentation to navigate the complex regulatory landscape successfully.

Globalization of clinical trials

The globalization of clinical trials represents another key driver of the clinical trial supplies market. Pharmaceutical companies are increasingly conducting trials in multiple countries to access diverse patient populations, expedite recruitment, and reduce costs. This trend is especially pronounced in emerging markets with significant patient pools. Consequently, the demand for clinical trial supplies is not limited to a specific region but has expanded globally. This driver also highlights the need for robust logistics and supply chain networks that can efficiently support trials conducted in various geographical locations, often with differing regulatory requirements. Furthermore, globalization necessitates adaptability in terms of language, culture, and local infrastructure, adding complexity to the supply chain management process.

Clinical Trial Supplies Industry Segmentation:

Breakup by Services:

  • Product Manufacturing
  • Packaging, Labeling and Storage
  • Logistics and Distribution

Logistics and distribution dominates the market

The logistics and distribution segment within the clinical trial supplies market is witnessing substantial growth due to the increasing globalization of clinical trials. As pharmaceutical companies expand their trials to diverse geographic locations, the need for efficient and reliable logistics and distribution networks becomes paramount. This includes ensuring timely delivery of supplies to various trial sites worldwide. Moreover, advancements in technology, such as the integration of blockchain and IoT, are revolutionizing supply chain management. These innovations enhance real-time tracking and monitoring of clinical trial supplies, leading to increased efficiency and reduced wastage. In line with this, the COVID-19 pandemic has underscored the importance of resilient and adaptable supply chains. Companies are now investing in robust logistics to ensure the uninterrupted flow of critical supplies, even in times of crisis. Furthermore, the emphasis on patient-centric approaches in clinical trials has led to the need for patient kits and direct-to-patient shipments. This trend requires specialized logistics solutions tailored to individual patient needs.

Breakup by Phase:

  • Phase I
  • Phase II
  • Phase III
  • Others

Phase III dominates the market

The phase III segment dominates the market as it represents the pivotal stage in evaluating a drug's efficacy and safety, making it a critical step in the regulatory approval process. This regulatory focus drives pharmaceutical companies to invest significantly in phase III trials. Moreover, as drugs progress through earlier phases, the sample size required for phase III trials increases substantially, translating into higher demand for clinical trial supplies. Additionally, phase III trials often involve a global patient population, necessitating comprehensive supply chain logistics to ensure the timely delivery of materials to diverse sites. In line with this, the increasing complexity of drug development, particularly in areas like oncology and rare diseases, necessitates larger and more complex phase III trials. This complexity includes the need for specialized supplies, patient-centric approaches, and adaptive trial designs. Furthermore, the demand for phase III trials is influenced by market dynamics, including competition and the need for differentiation in therapeutic areas. Companies seek to demonstrate superior efficacy and safety profiles, making phase III trials a pivotal stage in their product development strategies.

Breakup by Therapeutic Area:

  • Oncology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Central Nervous System (CNS) And Mental Disorders
  • Others

Oncology dominates the market

The oncology segment is experiencing significant growth within the clinical trial supplies market, primarily driven by the escalating global incidence of cancer. With cancer being one of the leading causes of mortality worldwide, pharmaceutical companies are increasingly investing in oncology-focused clinical trials to develop novel therapies and treatments. Moreover, advances in cancer research and the identification of specific biomarkers have led to the development of targeted therapies. This trend has necessitated the need for specialized clinical trial supplies tailored to the unique requirements of oncology trials, such as precision medicine tools and specialized diagnostics. Furthermore, regulatory agencies are expediting approvals for promising oncology drugs, encouraging pharmaceutical companies to accelerate their research efforts. Consequently, there is a growing demand for clinical trial supplies to support these fast-paced trials. Besides this, collaborations between pharmaceutical firms and academic institutions or research organizations are fostering innovation in oncology research. This partnership-driven approach is increasing the scope and complexity of clinical trials, thereby boosting the demand for clinical trial supplies.

Breakup by End-Use Industry:

  • Medical Device Industry
  • Biopharmaceuticals Industry
  • Pharmaceuticals Industry
  • Others

Pharmaceuticals industry hold the largest share in the market

The pharmaceuticals segment is experiencing substantial growth driven by the increasing global burden of chronic diseases, including cancer, cardiovascular ailments, and diabetes, which has led to a heightened demand for innovative drugs and therapies. Moreover, regulatory reforms and evolving healthcare policies are shaping the industry landscape. Stringent regulations and guidelines, particularly in developed markets, necessitate compliance and adherence to safety standards. This environment promotes innovation and the development of high-quality pharmaceutical products. Furthermore, advancements in biotechnology and genomics have ushered in an era of precision medicine. Tailoring treatments to individual patient profiles is becoming more common, driving research and development efforts in the pharmaceutical sector. Apart from this, the emergence of biosimilars and orphan drugs is expanding the pharmaceutical market's scope. Biosimilars offer cost-effective alternatives to biologics, while orphan drugs target rare diseases, presenting lucrative opportunities for pharmaceutical companies.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest clinical trial supplies market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represented the largest segment.

North America's clinical trial supplies market is witnessing substantial growth, fueled by the region's well-established pharmaceutical and biotechnology sector, coupled with a robust healthcare infrastructure, creates a conducive environment for clinical trials. Moreover, regulatory agencies like the FDA in the United States have streamlined approval processes, encouraging pharmaceutical companies to conduct trials in the region. In line with this, North America's diverse patient populations and access to specialized healthcare facilities make it an attractive destination for clinical trials across various therapeutic areas. Furthermore, the increasing prevalence of chronic diseases, such as diabetes and cancer, drives the demand for clinical trials to develop innovative treatments. Additionally, the emergence of cutting-edge technologies like genomics and precision medicine is propelling North America's position as a hub for advanced clinical research. The pandemic's impact has also accelerated the adoption of virtual and decentralized trials in the region, further contributing to market growth.

Competitive Landscape:

The competitive landscape of the clinical trial supplies market is characterized by a dynamic interplay of various stakeholders, each contributing to the industry's growth and evolution. Service providers in this sector offer a wide range of solutions, including clinical packaging, labeling, distribution, and logistics services, making it a highly specialized and competitive field. Key players in the market differentiate themselves through their global reach, technological capabilities, regulatory compliance, and ability to cater to diverse therapeutic areas. These companies often form strategic partnerships with pharmaceutical and biotechnology firms to provide end-to-end solutions for clinical trials. In addition to established companies, the market also sees the emergence of niche players focusing on specific areas such as direct-to-patient services, temperature-sensitive logistics, and innovative supply chain technologies. These specialized firms cater to the evolving needs of the industry, offering unique solutions to enhance efficiency and cost-effectiveness. Moreover, the market's competitive landscape is influenced by regulatory changes, as compliance with stringent standards is imperative. This factor underscores the importance of choosing suppliers with a proven track record in maintaining the highest quality and compliance levels.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Almac Group Ltd.
  • Catalent Pharma Solutions Inc.
  • DHL
  • Parexel
  • Thermo Fisher Scientific Inc.
  • PCI Services
  • Sharp Clinical
  • Biocair
  • Movianto

Key Questions Answered in This Report:

  • How has the global clinical trial supplies market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global clinical trial supplies market?
  • What is the impact of each driver, restraint, and opportunity on the global clinical trial supplies market?
  • What are the key regional markets?
  • Which countries represent the most attractive clinical trial supplies market?
  • What is the breakup of the market based on the services?
  • Which are the most attractive services in the clinical trial supplies market?
  • What is the breakup of the market based on the phase?
  • Which is the most attractive phase in the clinical trial supplies market?
  • What is the breakup of the market based on the therapeutic area?
  • Which is the most attractive therapeutic area in the clinical trial supplies market?
  • What is the breakup of the market based on end-use industry?
  • Which is the most attractive end-use industry in the clinical trial supplies market?
  • What is the competitive structure of the global clinical trial supplies market?
  • Who are the key players/companies in the global clinical trial supplies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Trial Supplies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Services

  • 6.1 Product Manufacturing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Packaging, Labeling and Storage
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Logistics and Distribution
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Phase

  • 7.1 Phase I
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Phase II
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Phase III
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Therapeutic Area

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cardiovascular Diseases
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Respiratory Diseases
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 CNS and Mental Disorders
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-Use Industry

  • 9.1 Medical Device Industry
    • 9.1.1 Market Trends
    • 9.1.3 Market Forecast
  • 9.2 Biopharmaceuticals Industry
    • 9.2.1 Market Trends
    • 9.2.3 Market Forecast
  • 9.3 Pharmaceuticals Industry
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.3 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Almac Group Ltd.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Catalent Pharma Solutions Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 DHL
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Parexel
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Thermo Fisher Scientific Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 PCI Services
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Sharp Clinical
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Biocair
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Movianto
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Clinical Trial Supplies Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Trial Supplies Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Clinical Trial Supplies Market: Breakup by Services (in %), 2024
  • Figure 4: Global: Clinical Trial Supplies Market: Breakup by Phase (in %), 2024
  • Figure 5: Global: Clinical Trial Supplies Market: Breakup by Therapeutic Area (in %), 2024
  • Figure 6: Global: Clinical Trial Supplies Market: Breakup by End-Use Industry (in %), 2024
  • Figure 7: Global: Clinical Trial Supplies Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Clinical Trial Supplies Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 9: Global: Clinical Trial Supplies (Product Manufacturing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Clinical Trial Supplies (Product Manufacturing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Clinical Trial Supplies (Packaging, Labeling and Storage) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Clinical Trial Supplies (Logistics and Distribution) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Clinical Trial Supplies (Logistics and Distribution) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Clinical Trial Supplies (Phase I) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Clinical Trial Supplies (Phase I) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Clinical Trial Supplies (Phase II) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Clinical Trial Supplies (Phase II) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Clinical Trial Supplies (Phase III) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Clinical Trial Supplies (Phase III) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Clinical Trial Supplies (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Clinical Trial Supplies (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Clinical Trial Supplies (Cardiovascular Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Clinical Trial Supplies (Respiratory Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Clinical Trial Supplies (Respiratory Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Clinical Trial Supplies (CNS and Mental Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Clinical Trial Supplies (Medical Devices Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Clinical Trial Supplies (Medical Devices Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Clinical Trial Supplies (Biopharmaceuticals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Clinical Trial Supplies (Pharmaceuticals Industry) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Clinical Trial Supplies (Others) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Clinical Trial Supplies (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: North America: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: North America: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: United States: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: United States: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Canada: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Canada: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Asia Pacific: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Asia Pacific: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: China: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: China: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Japan: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Japan: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: India: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: India: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: South Korea: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: South Korea: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Australia: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Australia: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Indonesia: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Indonesia: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Others: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Europe: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Europe: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Germany: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Germany: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: France: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: France: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: United Kingdom: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: United Kingdom: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Italy: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Italy: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Spain: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Spain: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Russia: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Russia: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Latin America: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Latin America: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Brazil: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Brazil: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Mexico: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Mexico: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Middle East and Africa: Clinical Trial Supplies Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Middle East and Africa: Clinical Trial Supplies Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Global: Clinical Trial Supplies Industry: SWOT Analysis
  • Figure 90: Global: Clinical Trial Supplies Industry: Value Chain Analysis
  • Figure 91: Global: Clinical Trial Supplies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Trial Supplies Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Clinical Trial Supplies Market Forecast: Breakup by Services (in Million USD), 2025-2033
  • Table 3: Global: Clinical Trial Supplies Market Forecast: Breakup by Phase (in Million USD), 2025-2033
  • Table 4: Global: Clinical Trial Supplies Market Forecast: Breakup by Therapeutic Area (in Million USD), 2025-2033
  • Table 5: Global: Clinical Trial Supplies Market Forecast: Breakup by End-Use Industry (in Million USD), 2025-2033
  • Table 6: Global: Clinical Trial Supplies Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Clinical Trial Supplies Market: Competitive Structure
  • Table 8: Global: Clinical Trial Supplies Market: Key Players